AFMD Financial Statements

Balance sheet, income statement, cash flow, and dividends for Affimed Nv (AFMD).


€93.34M Market Cap.

As of 03/28/2024 5:00 PM ET (MRY) • Disclaimer

AFMD Market Cap. (MRY)


AFMD Shares Outstanding (MRY)


AFMD Assets (MRY)


Total Assets

€97.16M

Total Liabilities

€39.35M

Total Investments

€34.37M

AFMD Income (MRY)


Revenue

€8.28M

Net Income

-€105.94M

Operating Expense

€114.94M

AFMD Cash Flow (MRY)


CF Operations

-€110.27M

CF Investing

-€36.06M

CF Financing

-€6.22M

AFMD Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

AFMD Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

€97,157,000 (-51.55%)

€200,512,000 (-10.94%)

€225,135,000 (28.12%)

€175,725,000 (56.40%)

Assets Current

€84,188,000 (-57.06%)

€196,070,000 (-5.00%)

€206,394,000 (36.87%)

€150,799,000 (42.38%)

Assets Non-Current

€12,969,000 (191.96%)

€4,442,000 (-76.30%)

€18,741,000 (-24.81%)

€24,926,000 (286.75%)

Goodwill & Intangible Assets

€25,000 (-56.90%)

€58,000 (-96.39%)

€1,607,000 (-6.46%)

€1,718,000 (1154.01%)

Shareholders Equity

€57,807,000 (-62.20%)

€152,915,000 (12.48%)

€135,951,000 (88.84%)

€71,993,000 (86.19%)

Property Plant & Equipment Net

€12,944,000 (195.26%)

€4,384,000 (-8.40%)

€4,786,000 (51.17%)

€3,166,000 (1.64%)

Cash & Equivalents

€38,529,000 (-79.75%)

€190,286,000 (-3.72%)

€197,630,000 (34.58%)

€146,854,000 (54.20%)

Accumulated Other Comprehensive Income

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Deferred Revenue

€1,083,000 (-89.52%)

€10,331,000 (-79.99%)

€51,633,000 (-43.29%)

€91,041,000 (53.49%)

Total Investments

€34,369,000 (0%)

€0 (0%)

€12,348,000 (-38.39%)

€20,042,000 (65.70%)

Investments Current

€34,369,000 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Investments Non-Current

€0 (0%)

€0 (0%)

€12,348,000 (-38.39%)

€20,042,000 (527.69%)

Inventory

€463,000 (-26.27%)

€628,000 (49.17%)

€421,000 (71.14%)

€246,000 (-16.89%)

Trade & Non-Trade Receivables

€5,327,000 (97.52%)

€2,697,000 (-43.92%)

€4,809,000 (97.17%)

€2,439,000 (64.57%)

Trade & Non-Trade Payables

€18,916,000 (-0.84%)

€19,077,000 (1.15%)

€18,860,000 (65.53%)

€11,394,000 (6.75%)

Accumulated Retained Earnings (Deficit)

-€536,128,000 (-24.63%)

-€430,190,000 (-29.03%)

-€333,397,000 (-20.85%)

-€275,874,000 (-17.64%)

Tax Assets

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Tax Liabilities

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Total Debt

€19,351,000 (6.39%)

€18,189,000 (-2.69%)

€18,691,000 (1341.09%)

€1,297,000 (-59.30%)

Debt Current

€6,372,000 (0.73%)

€6,326,000 (400.87%)

€1,263,000 (116.27%)

€584,000 (-77.85%)

Debt Non-Current

€12,979,000 (9.41%)

€11,863,000 (-31.93%)

€17,428,000 (2344.32%)

€713,000 (29.64%)

Total Liabilities

€39,350,000 (-17.33%)

€47,597,000 (-46.63%)

€89,184,000 (-14.02%)

€103,732,000 (40.76%)

Liabilities Current

€25,907,000 (-25.23%)

€34,651,000 (-46.32%)

€64,547,000 (-3.70%)

€67,027,000 (90.52%)

Liabilities Non-Current

€13,443,000 (3.84%)

€12,946,000 (-47.45%)

€24,637,000 (-32.88%)

€36,705,000 (-4.69%)

AFMD Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

€8,275,000 (-79.99%)

€41,353,000 (2.45%)

€40,366,000 (42.33%)

€28,360,000 (32.58%)

Cost of Revenue

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Selling General & Administrative Expense

€24,675,000 (-23.07%)

€32,075,000 (32.44%)

€24,218,000 (76.58%)

€13,715,000 (33.60%)

Research & Development Expense

€94,958,000 (-3.90%)

€98,814,000 (21.26%)

€81,488,000 (63.01%)

€49,989,000 (14.15%)

Operating Expenses

€114,936,000 (-11.23%)

€129,472,000 (24.02%)

€104,396,000 (65.50%)

€63,078,000 (17.32%)

Interest Expense

-€726,000 (65.71%)

-€2,117,000 (67.48%)

-€6,509,000 (-197.92%)

€6,647,000 (44413.33%)

Income Tax Expense

€3,000 (50.00%)

€2,000 (0.00%)

€2,000 (100.00%)

€1,000 (-75.00%)

Net Loss Income from Discontinued Operations

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Consolidated Income

-€105,938,000 (-23.18%)

-€86,004,000 (-49.51%)

-€57,523,000 (-39.06%)

-€41,366,000 (-27.81%)

Net Income to Non-Controlling Interests

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Net Income

-€105,938,000 (-23.18%)

-€86,004,000 (-49.51%)

-€57,523,000 (-39.06%)

-€41,366,000 (-27.81%)

Preferred Dividends Income Statement Impact

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Net Income Common Stock

-€105,938,000 (-23.18%)

-€86,004,000 (-49.51%)

-€57,523,000 (-39.06%)

-€41,366,000 (-27.81%)

Weighted Average Shares

€14,939,916 (-89.51%)

€142,362,294 (19.13%)

€119,502,384 (43.17%)

€83,471,559 (29.93%)

Weighted Average Shares Diluted

€14,939,916 (-89.51%)

€142,362,294 (19.13%)

€119,502,384 (43.17%)

€83,471,559 (29.93%)

Earning Before Interest & Taxes (EBIT)

-€106,661,000 (-21.04%)

-€88,119,000 (-37.62%)

-€64,030,000 (-84.43%)

-€34,718,000 (-7.23%)

Gross Profit

€8,275,000 (-79.99%)

€41,353,000 (2.45%)

€40,366,000 (42.33%)

€28,360,000 (32.58%)

Operating Income

-€106,661,000 (-21.04%)

-€88,119,000 (-37.62%)

-€64,030,000 (-84.43%)

-€34,718,000 (-7.23%)

AFMD Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-€36,059,000 (-743.34%)

€5,605,000 (245.58%)

-€3,850,000 (-148.09%)

€8,006,000 (84.47%)

Net Cash Flow from Financing

-€6,220,000 (-107.02%)

€88,557,000 (-33.71%)

€133,581,000 (92.89%)

€69,252,000 (165.97%)

Net Cash Flow from Operations

-€110,269,000 (-5.13%)

-€104,892,000 (-21.13%)

-€86,591,000 (-346.35%)

-€19,400,000 (33.23%)

Net Cash Flow / Change in Cash & Cash Equivalents

-€152,548,000 (-1321.70%)

-€10,730,000 (-124.87%)

€43,140,000 (-25.44%)

€57,858,000 (4276.55%)

Net Cash Flow - Business Acquisitions and Disposals

€978,000

-

-

-

Net Cash Flow - Investment Acquisitions and Disposals

-€33,308,000 (-628.61%)

€6,301,000 (0%)

€0 (0%)

€8,446,000 (45.27%)

Capital Expenditure

-€3,729,000 (-465.86%)

-€659,000 (69.99%)

-€2,196,000 (-409.51%)

-€431,000 (67.45%)

Issuance (Repayment) of Debt Securities

-€6,420,000 (-388.96%)

-€1,313,000 (-107.80%)

€16,844,000 (735.86%)

-€2,649,000 (15.10%)

Issuance (Purchase) of Equity Shares

€200,000 (-99.78%)

€89,870,000 (-23.22%)

€117,048,000 (62.79%)

€71,901,000 (146.59%)

Payment of Dividends & Other Cash Distributions

€0

-

-

-

Effect of Exchange Rate Changes on Cash

€791,000 (-76.64%)

€3,386,000 (-55.66%)

€7,636,000 (222.41%)

-€6,238,000 (-580.26%)

Share Based Compensation

€10,714,000 (-43.94%)

€19,110,000 (61.68%)

€11,820,000 (249.60%)

€3,381,000 (36.94%)

Depreciation Amortization & Accretion

€1,749,000 (-39.67%)

€2,899,000 (117.32%)

€1,334,000 (19.64%)

€1,115,000 (23.07%)

AFMD Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-1280.20% (-515.48%)

-208.00% (-45.96%)

-142.50% (2.33%)

-145.90% (3.57%)

EBITDA Margin

-1267.80% (-515.14%)

-206.10% (-32.71%)

-155.30% (-31.05%)

-118.50% (19.44%)

Return on Average Equity (ROAE)

-118.30% (-121.54%)

-53.40% (-36.92%)

-39.00% (55.07%)

-86.80% (8.54%)

Return on Average Assets (ROAA)

-81.40% (-110.88%)

-38.60% (-61.51%)

-23.90% (30.32%)

-34.30% (-7.86%)

Return on Sales (ROS)

-1289.00% (-504.88%)

-213.10% (-34.36%)

-158.60% (-29.58%)

-122.40% (19.15%)

Return on Invested Capital (ROIC)

-413.60% (-152.66%)

785.40% (238.53%)

232.00% (60.22%)

144.80% (118.80%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.79 (59.19%)

-1.94 (80.80%)

-10.12 (-6.02%)

-9.54 (-95.71%)

Price to Sales Ratio (P/S)

10.16 (153.08%)

4.01 (-72.10%)

14.38 (2.38%)

14.05 (91.79%)

Price to Book Ratio (P/B)

1.45 (27.68%)

1.14 (-67.60%)

3.51 (-30.52%)

5.05 (28.40%)

Debt to Equity Ratio (D/E)

0.68 (118.97%)

0.31 (-52.59%)

0.66 (-54.48%)

1.44 (-24.40%)

Earnings Per Share (EPS)

-7.09 (-1081.67%)

-0.6 (-25.00%)

-0.48 (4.00%)

-0.5 (0.00%)

Sales Per Share (SPS)

0.61 (99.03%)

0.31 (-19.53%)

0.38 (-7.25%)

0.41 (10.70%)

Free Cash Flow Per Share (FCFPS)

-7.63 (-929.69%)

-0.74 (0.27%)

-0.74 (-212.18%)

-0.24 (49.68%)

Book Value Per Share (BVPS)

3.87 (260.24%)

1.07 (-5.62%)

1.14 (32.02%)

0.86 (43.19%)

Tangible Assets Book Value Per Share (TABVPS)

6.5 (361.79%)

1.41 (-24.71%)

1.87 (-10.31%)

2.08 (19.35%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-4 (50.00%)

-8 (-166.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.42 (-281.03%)

0.23 (105.08%)

-4.57 (45.17%)

-8.34 (-171.35%)

Asset Turnover

0.06 (-65.59%)

0.19 (11.38%)

0.17 (-28.94%)

0.23 (11.90%)

Current Ratio

3.25 (-42.56%)

5.66 (76.92%)

3.2 (42.13%)

2.25 (-25.27%)

Dividends

€0 (0%)

€0 (0%)

€0 (0%)

€0 (0%)

Free Cash Flow (FCF)

-€113,998,000 (-8.00%)

-€105,551,000 (-18.88%)

-€88,787,000 (-347.72%)

-€19,831,000 (34.72%)

Enterprise Value (EV)

€48,931,765 (332.47%)

-€21,048,518 (-106.46%)

€325,673,246 (-4.66%)

€341,587,070 (214.52%)

Earnings Before Tax (EBT)

-€105,935,000 (-23.18%)

-€86,002,000 (-49.51%)

-€57,521,000 (-39.06%)

-€41,365,000 (-27.82%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-€104,912,000 (-23.11%)

-€85,220,000 (-35.93%)

-€62,696,000 (-86.58%)

-€33,603,000 (-6.78%)

Invested Capital

€52,047,000 (926.93%)

-€6,294,000 (68.46%)

-€19,958,000 (48.26%)

-€38,577,000 (-157.08%)

Working Capital

€58,281,000 (-63.89%)

€161,419,000 (13.80%)

€141,847,000 (69.33%)

€83,772,000 (18.43%)

Tangible Asset Value

€97,132,000 (-51.54%)

€200,454,000 (-10.32%)

€223,528,000 (28.46%)

€174,007,000 (55.06%)

Market Capitalization

€93,337,084 (-49.60%)

€185,180,775 (-65.87%)

€542,546,078 (22.26%)

€443,774,424 (159.43%)

Average Equity

€89,560,750 (-44.39%)

€161,064,500 (9.28%)

€147,381,500 (209.14%)

€47,674,250 (39.81%)

Average Assets

€130,072,500 (-41.61%)

€222,766,750 (-7.57%)

€241,019,750 (100.09%)

€120,456,750 (18.28%)

Invested Capital Average

€25,787,750 (329.84%)

-€11,219,750 (59.34%)

-€27,593,750 (-15.07%)

-€23,980,750 (-670.53%)

Shares

14,933,934 (-90.00%)

149,339,335 (51.94%)

98,287,333 (28.90%)

76,249,901 (22.14%)